Coronary Artery Disease
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
-2518A>G polymorphism of MCP-1 does not seem to contribute substantially to CAD in Han Chinese.
|
19332042 |
2009 |
Coronary Artery Disease
|
0.400 |
Biomarker
|
disease |
BEFREE |
MCP-1 G-2518, SDF-1beta A801, and CCR5 Delta32 were not associated with CAD.
|
15302103 |
2004 |
Coronary Artery Disease
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Monocyte chemoattractant protein-1-2518 G/A polymorphism, plasma levels, and premature stable coronary artery disease.
|
19247801 |
2010 |
Coronary Artery Disease
|
0.400 |
AlteredExpression
|
disease |
BEFREE |
MCP-1 mRNA expression level was increased histone H3/H4 acetylation levels in MCP-1 promoter were markedly increased in monocytes of CAD patients.
|
29609686 |
2018 |
Coronary Artery Disease
|
0.400 |
Biomarker
|
disease |
BEFREE |
After the MCODE analysis, the top 4 high degree genes, including interleukin 1 beta (IL1B, degree = 29), intercellular adhesion molecule 1 (ICAM1, degree = 25), Jun proto-oncogene (JUN, degree = 23) and C-C motif chemokine ligand 2 (CCL2, degree = 20) had been identified to validate in RT-PCR and Cox proportional hazards regression between CAD and normals.
|
30961613 |
2019 |
Coronary Artery Disease
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Both lower and higher MCP-1 levels are associated with an increased risk of all-cause and CVD mortality among CAD patients.
|
25786118 |
2015 |
Coronary Artery Disease
|
0.400 |
AlteredExpression
|
disease |
BEFREE |
Compared to controls, there were no associations between circulating levels of IL-8, lipocalin-2, nerve growth factor (NGF), RANTES, CD-163, GPX-3, monocyte chemotactic protein-1 (MCP-1)/CCL2, leptin, soluble vascular endothelial growth factor receptor-1 (sFLT1), fatty acid binding protein-4 (FABP-4), and plasminogen activator inhibitor-1 (PAI-1) and increases in their gene expression in EAT adjacent to CAD.
|
21679057 |
2011 |
Coronary Artery Disease
|
0.400 |
Biomarker
|
disease |
BEFREE |
Comparison of gene expression pattern between CAD and MetS revealed significantly higher expression of leukotriene genes - arachidonate 5-lipoxygenase (ALOX5), arachidonate 5-lipoxygenase activating protein (ALOX5 AP), leukotriene A4 hydrolase (LTA4H) and leukotriene C4 synthase (LTC4S), and lower expression of NF-κB, interleukin 1 beta (IL-1β), monocyte chemoattractant protein-1 (MCP-1/CCL2) and signal transducer and activator of transcription 3 (STAT3) genes in CAD.
|
29067980 |
2017 |
Coronary Artery Disease
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Controversial results regarding the association of the -2518G/A polymorphism of the MCP-1 gene with coronary artery disease (CAD) have been reported.
|
18230355 |
2008 |
Coronary Artery Disease
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Currently, there is conflicting evidence regarding an association between polymorphisms in CCR2/MCP-1 and CCR5/RANTES and coronary artery disease.
|
15017357 |
2004 |
Coronary Artery Disease
|
0.400 |
Biomarker
|
disease |
BEFREE |
Effects of crocin and saffron aqueous extract on gene expression of SIRT1, AMPK, LOX1, NF-κB, and MCP-1 in patients with coronary artery disease: A randomized placebo-controlled clinical trial.
|
31797473 |
2019 |
Coronary Artery Disease
|
0.400 |
AlteredExpression
|
disease |
BEFREE |
Genetically determined higher MCP-1 levels were further associated with coronary artery disease (OR, 1.04; 95% CI, 1.00-1.08; P=0.04) and myocardial infarction (OR, 1.05; 95% CI, 1.01-1.09; P=0.02), but not with atrial fibrillation.
|
30586705 |
2019 |
Coronary Artery Disease
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
In MCP1 rs1024611 SNP analysis, homozygous mutation was significantly more common in the OSAS + CAD group than in the OSAS and control groups (p < 0.001).
|
31388753 |
2019 |
Coronary Artery Disease
|
0.400 |
Biomarker
|
disease |
BEFREE |
In a necropsy study, we used immunohistochemistry to explore where and to what extent CCL2 and related receptors are present in diseased arteries that caused the death of men with coronary artery disease compared with unaffected arteries.
|
31739217 |
2020 |
Coronary Artery Disease
|
0.400 |
AlteredExpression
|
disease |
BEFREE |
In serum, there was significant up-regulation in TNF-α, IL-8, and MCP-1 and obvious down-regulation in INF-β and IP-10 with severity of CAD.
|
24146036 |
2014 |
Coronary Artery Disease
|
0.400 |
AlteredExpression
|
disease |
BEFREE |
In this respect, increased expression of MCP-1 and the corresponding receptor CCR2 have been demonstrated in renal transplant rejection and coronary artery disease.
|
12239249 |
2002 |
Coronary Artery Disease
|
0.400 |
Biomarker
|
disease |
BEFREE |
In this study, in order to determine the role of CCR2, a receptor for MCP-1, in the development of CAD, we initially sequenced and identified the genetic variants of CCR2 using 24 unrelated Korean individuals' DNA samples.
|
17482150 |
2007 |
Coronary Artery Disease
|
0.400 |
AlteredExpression
|
disease |
BEFREE |
In this study, we investigated whether RFX1 and epigenetic modifications mediated by RFX1 contribute to the overexpression of MCP1 in activated monocytes in CAD patients.
|
31737059 |
2019 |
Coronary Artery Disease
|
0.400 |
Biomarker
|
disease |
BEFREE |
Interestingly, the mRNA levels of IL-6, IL-1beta, MCP-1, natriuretic peptide receptor-C (NPR-C), adrenomedullin, and leptin in epicardial adipose tissue were higher in patients with CAD than those without CAD.
|
20691218 |
2010 |
Coronary Artery Disease
|
0.400 |
AlteredExpression
|
disease |
BEFREE |
Moreover, at proteins level pERK1/2 (p = 0.05), NF-kB (p = 0.017), MCP-1 (p = 0.011) was higher and IkkB expression was lower (p = 0.038) in cHSP60-positive atheromatous plaque of CAD patients.
|
21192737 |
2011 |
Coronary Artery Disease
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Our data demonstrate that MCP-1 -2518 A>G polymorphism is not associated with premature CAD in Turkish patients.
|
18651322 |
2008 |
Coronary Artery Disease
|
0.400 |
Biomarker
|
disease |
BEFREE |
Our data do not support previous publications indicating that MCP-1 is involved in the pathogenesis of CAD.
|
20431065 |
2010 |
Coronary Artery Disease
|
0.400 |
AlteredExpression
|
disease |
BEFREE |
Patients with CAD showed higher constitutive expression of CCL2, CXCL8, CXCL9, CXCL10 and IFN-gamma mRNA and, after stimulation with oxLDL, higher expression of CCL2 and CXCL8 mRNA than the control group.
|
18617279 |
2009 |
Coronary Artery Disease
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Results indicated a significant association between MCP-1 -2548 gene polymorphism and susceptibility to CAD.
|
22752804 |
2012 |
Coronary Artery Disease
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Results of the present study suggests that G-allele of MCP-1 -2518A>G polymorphism is associated with reduced risk of T2D and increased risk of CAD in the population of Punjab.
|
23930970 |
2013 |